为解决 CML - LSCs 导致的治疗难题，重庆医科大学的研究人员开展了 CAR - 巨噬细胞靶向 CD26 消除 CML - LSCs 的研究。结果表明该疗法有效，为 CML 治疗提供新思路。强烈推荐科研读者阅读，一同探索血液肿瘤治疗新方向！

STI571 specifically inhibits ABL1 protein tyrosine kinase, and these results elegantly illustrate the power of research founded on a good understanding of the underlying mechanisms of biological ...

The BCR/ABL1 inhibitor Nilotinib is increasingly used ... in endothelial cells Drug-exposed HUVEC were examined for protein- and mRNA expression levels of ICAM-1 (CD54), E-selectin (CD62E ...

BCR-ABL1 is a result of two genes mistakenly getting ... MPL is the gene for a protein called thrombopoietin receptor that plays a major role in white blood cell growth and survival.